Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jan 24, 2022 11:45pm
183 Views
Post# 34356557

RE:New Shares Outstanding - AVRT milestone achieved?

RE:New Shares Outstanding - AVRT milestone achieved?

There were only a couple sites that still listed outstanding shares at 88.233 likely just not updated yet. Majority of sites have 96.233 as the new shares outstanding. 

In order to get the 8 million in shares AVRT must hit the milestone of generating $4 million USD in revenue between Sept 2021 and Dec 2022.

Total revenue for Q3 (July-Sept) was $684k.  Assume that is 100% AVRT that leaves $3.3 million in revenue needed from Oct 2021 - Jan 2022 or an average of about $1 million a month. 

If Heath Clinics achieved the milestone and shares were released that would signal a very siginificant increase in revenue with a trend of $1 million a month    

LithLover wrote: Anyone else notice the shares outstanding has now moved up to 96.233 million.

The financials dated Nov 15, 2021 had oustanding shares at 78,858,281 (page 4)

Add in the shares from the Private placement issued on November 26,2021 to HC Wainwright of 9,375,002.  

New total of 88,233,283

Total outstanding shares now showing on Rueters, RBC and other sites is 96,233,283 a difference of 8,000,000 shares.   Did they just issue the 8 million shares to Health Clinics?

 

"8M shares to be paid should the acquired Health Clinics businesses achieve certain revenue performance milestones.  The milestones are the generation of US$4M in revenue from the AVRT program over any consecutive 12 month period from September 2021 to December 2022."


The 96 million outstanding was recently updated.  So did they just hit the $4 million ($5.2 million CAD) in revenue over the last 5 months (Sept 2021-Jan 2022) from AVRT?

If the shares were just being held in escrow why wasn't outstanding shares updated back in December after the vote?

 



<< Previous
Bullboard Posts
Next >>